XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (2,677) $ (6,351)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization expense 40,146 34,737
Equity in income of joint ventures (3,858) (2,436)
Stock-based compensation expense 5,070 4,171
Elimination of unrealized (loss) gain on sales to joint ventures (741) 39
Changes in fair value of contingent consideration 398 0
Deferred taxes (1,071) (5,225)
Unrealized foreign exchange 660 (1,753)
Changes in assets and liabilities:    
Accounts receivable, net 29,332 (5,761)
Inventories (17,286) (2,380)
Other assets (7,629) (11,320)
Accounts payable and accrued liabilities (14,570) 5,362
Other liabilities 2,755 11,306
Income taxes, net 1,391 3,929
Other (1,982) (2,995)
Net cash provided by operating activities 29,938 21,323
Cash flows from investing activities:    
Capital expenditures (30,739) (28,776)
Payment for acquisition of business, net of cash acquired 0 (7,536)
Net cash used in investing activities (30,739) (36,312)
Cash flows from financing activities:    
Release of (cash pledged for) collateral deposits, net 650 (10)
Proceeds from borrowings 21,204 0
Acquisition of common stock 0 (10,011)
Payment of withholding taxes on stock-based compensation plans (4,095) (2,954)
Repayment of financed insurance premium (2,327) (2,899)
Repayment of finance leases (541) (499)
Net cash provided by (used in) financing activities 14,891 (16,373)
Effect of exchange rate changes on cash and cash equivalents (2,722) (800)
Net increase (decrease) to cash and cash equivalents and restricted cash 11,368 (32,162)
Cash and cash equivalents and restricted cash at beginning of period 153,166 218,460
Cash and cash equivalents and restricted cash at end of period $ 164,534 $ 186,298